Physician profile
Cynthia Beatty
NPI 1114256658
$1,994.61
in general payments reported to CMS, 2019-2025
15 companies · $349 in 2025
The $349 reported for 2025 was more than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
See the full distribution for Neurology with Special Qualifications in Child Neurology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $611 · 2020: $106 · 2021: $165 · 2022: $146 · 2023: $334 · 2024: $282 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $966.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $965.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $532.45 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator, Vns Therapy |
| Biogen, INC. | $406.20 | 2019-2025 | Spinraza |
| Jazz Pharmaceuticals INC. | $292.22 | 2023-2024 | |
| Ucb, INC. | $226.46 | 2023-2025 | Nayzilam, Fintepla |
| Mallinckrodt Enterprises LLC | $124.99 | 2019 | |
| Neurelis, INC. | $104.87 | 2021-2024 | Valtoco |
| Supernus Pharmaceuticals, INC. | $56.05 | 2021-2022 | |
| Sk Life Science, INC. | $53.53 | 2025 | |
| Mallinckrodt Hospital Products INC. | $42.63 | 2020 | |
| Acadia Pharmaceuticals INC | $42.25 | 2023-2024 | Daybue |
| Alexion Pharmaceuticals, INC. | $39.92 | 2023-2025 | Koselugo |
| Upsher-Smith Laboratories LLC | $27.99 | 2025 | |
| Genzyme Corporation | $25.05 | 2021 | |
| Biomarin Pharmaceutical INC. | $20.00 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia Beatty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.